Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FU9XY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,103
Award facts
- Contract value 100% obligated
- $8,103.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,103.33 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on August 26, 2025, with completion expected by August 27, 2025. This firm fixed-price, competitively awarded delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a primary vendor for DLA medical procurement and serves critical healthcare customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, generic drugs, vaccines, and medical supplies. This delivery order for Ondansetron—an anti-nausea medication commonly used in clinical and military healthcare settings—exemplifies the routine, competitively procured pharmaceutical deliveries that support DLA's mission to sustain military medical readiness and healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FU9XY?
SPE2DB25FU9XY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FU9XY worth?
The government has obligated $8,103 on SPE2DB25FU9XY.
Is contract SPE2DB25FU9XY an order under another contract?
Yes. SPE2DB25FU9XY is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9XY competed?
The extent of competition for SPE2DB25FU9XY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award